SynthesisFrontiers in nutrition2026

Immune-mediated renal injury and cardiometabolic risk in IgA nephropathy: clinical evidence on telitacicept from a scoping review.

Li Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.